MMD encodes a Golgi-resident scaffold protein that plays critical roles in lipid metabolism and cellular death pathways. The protein physically interacts with ACSL4 and MBOAT7 enzymes to promote polyunsaturated phosphatidylinositol remodeling, specifically increasing the incorporation of arachidonic acid into phosphatidylinositol lipids 1. This metabolic function renders cells more susceptible to ferroptosis, a form of regulated cell death characterized by iron-catalyzed lipid peroxidation 1. Recent multi-omic analyses have revealed significant disruption of ferroptosis pathways in Moyamoya disease patients, suggesting a potential connection between MMD dysfunction and this cerebrovascular disorder 2. The protein appears to function by targeting large intracellular structures and may have roles in antimicrobial responses, though much remains unknown about its complete cellular functions 3. While the gene name suggests involvement in monocyte-to-macrophage differentiation, the current evidence primarily supports its role in lipid metabolism regulation and ferroptosis susceptibility, with potential clinical relevance in cerebrovascular diseases.